This report provides data on the different sources and price ranges of HIV/AIDS drugs. It documents marketing information to help procurement agencies make informed decisions on the source of drugs; manufacturers interested in supplying HIV-related drugs and diagnostics at reduced prices; and the availability and price range of antiretroviral drugs for combination therapy. The report also includes information on essential drugs used to treat a wide range of opportunistic infections, pain-relieving drugs for use in palliative care, and drugs for the treatment of HIV/AIDS-related cancer. For the first time, it provides information on the range of test kits available for the diagnosis of HIV.